Vertex Pharmaceuticals VRTX Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's finite-lived intangible assets, accumulated amortization?
- Vertex Pharmaceuticals (VRTX) reported finite-lived intangible assets, accumulated amortization of $51.8M in Q1 2026.
- How has Vertex Pharmaceuticals's finite-lived intangible assets, accumulated amortization changed year-over-year?
- Vertex Pharmaceuticals's finite-lived intangible assets, accumulated amortization increased by 78.0% year-over-year, from $29.1M to $51.8M.